Determining the appropriate retatrutide dosage is essential for realizing optimal outcomes . Currently, clinical trials suggest a scope of dosing, usually starting at 2.4 mg once each day and progressively increasing to twelve milligrams once daily based on person response and tolerability . Higher doses, like the 16 mg option, are also being asses